Squarepoint’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Squarepoint’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.6K	Sell	23,807 -10,515	-31%	-$35.2K	﹤0.01%	4126
2025 Q4	$137K	Buy	34,322 +22,624	+193%	+$100K	﹤0.01%	3975
2025 Q3	$44.2K	Buy	+11,698	New	+$39.7K	﹤0.01%	4240
2023 Q4	–	Sell	-12,561	Closed	-$16.6K	–	4231
2023 Q3	$16.6K	Buy	+12,561	New	+$27.6K	﹤0.01%	3707
2023 Q1	–	Sell	-16,888	Closed	-$70.6K	–	3473
2022 Q4	$70.6K	Sell	16,888 -49,546	-75%	-$188K	﹤0.01%	3009
2022 Q3	$266K	Buy	66,434 +1,653	+3%	+$12.5K	﹤0.01%	2547
2022 Q2	$732K	Buy	+64,781	New	+$777K	﹤0.01%	1790
2022 Q1	–	Sell	-6,143	Closed	-$291K	–	3164
2021 Q4	$291K	Sell	6,143 -15,807	-72%	-$949K	﹤0.01%	2464
2021 Q3	$1.59M	Buy	21,950 +13,850	+171%	+$1M	﹤0.01%	1313
2021 Q2	$680K	Buy	+8,100	New	+$534K	﹤0.01%	1922

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint's NBP Position: Q1 2026 in Review

Squarepoint reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 31% in Q1 2026, selling an estimated $35.2K and leaving 23,807 shares worth $58.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4126.

Squarepoint first reported a position in NBP in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.59M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Squarepoint held 23,807 shares of NovaBridge Biosciences American Depositary Shares worth $58.6K as of Q1 2026.
Squarepoint sold 10,515 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $35.2K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4126 holding.
Squarepoint first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 10 quarters since.
Squarepoint's NovaBridge Biosciences American Depositary Shares position peaked at $1.59M in Q3 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.